(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CYP4A1 mRNA] CTD PMID:31150632 1-benzylpiperazine decreases expression EXP 6480464 N-benzylpiperazine results in decreased expression of CYP4A1 mRNA CTD PMID:26821219 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of CYP4A1 mRNA CTD PMID:30723492 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:20056577 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP4A1 mRNA CTD PMID:19969063 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP4A1 mRNA CTD PMID:32387183 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of CYP4A22 mRNA CTD PMID:21346803 2-methyl-2-[4-(1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]propanoic acid increases expression EXP 6480464 Nafenopin results in increased expression of CYP4A1 mRNA CTD PMID:18079279 and PMID:19647067 2-methyl-2-[4-(1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]propanoic acid multiple interactions EXP 6480464 Okadaic Acid inhibits the reaction [Nafenopin results in increased expression of CYP4A1 mRNA] and tautomycin inhibits the reaction [Nafenopin results in increased expression of CYP4A1 mRNA] CTD PMID:18079279 20-HETE multiple interactions EXP 6480464 20-hydroxy-5 more ... CTD PMID:11124159 and PMID:12388396 20-HETE increases chemical synthesis EXP 6480464 CYP4A1 protein results in increased chemical synthesis of 20-hydroxy-5 more ... CTD PMID:11124159 3-phenoxybenzoic acid increases expression EXP 6480464 3-phenoxybenzoic acid results in increased expression of CYP4A1 mRNA CTD PMID:32040184 4-tert-Octylphenol increases expression EXP 6480464 4-tert-octylphenol results in increased expression of CYP4A22 mRNA CTD PMID:17011747 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of CYP4A1 mRNA CTD PMID:24780913 amiodarone increases expression EXP 6480464 Amiodarone results in increased expression of CYP4A1 mRNA CTD PMID:12883083 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CYP4A1 mRNA CTD PMID:16483693 aristolochic acid A increases expression ISO CYP4A22 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of CYP4A22 mRNA CTD PMID:33212167 Aroclor 1254 decreases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of CYP4A1 mRNA CTD PMID:8471063 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of CYP4A1 mRNA and Chlorodiphenyl (54% Chlorine) results in increased expression of CYP4A1 protein CTD PMID:11163329 and PMID:8471063 azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CYP4A1 mRNA CTD PMID:33854195 barium sulfate increases expression EXP 6480464 Barium Sulfate results in increased expression of CYP4A1 mRNA CTD PMID:11124224 benoxaprofen increases expression EXP 6480464 benoxaprofen results in increased expression of CYP4A1 protein CTD PMID:2069584 benzene increases expression EXP 6480464 Benzene results in increased expression of CYP4A1 protein CTD PMID:8620572 benzo[a]pyrene increases methylation ISO CYP4A22 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of CYP4A22 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO CYP4A22 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of CYP4A22 mRNA CTD PMID:32234424 beta-naphthoflavone increases expression EXP 6480464 beta-Naphthoflavone results in increased expression of CYP4A1 mRNA CTD PMID:19969063 bexarotene increases expression EXP 6480464 bexarotene results in increased expression of CYP4A22 mRNA CTD PMID:16648578 bezafibrate increases expression EXP 6480464 Bezafibrate results in increased expression of CYP4A1 mRNA CTD PMID:19647067 bezafibrate multiple interactions EXP 6480464 Acetylcysteine promotes the reaction [Bezafibrate results in increased expression of CYP4A1 mRNA] CTD PMID:19647067 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of CYP4A1 and Diethylhexyl Phthalate results in increased expression of CYP4A1 mRNA CTD PMID:16954067 more ... bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CYP4A1 mRNA and bisphenol A affects the expression of CYP4A22 mRNA CTD PMID:25181051 and PMID:30903817 bisphenol A decreases methylation ISO CYP4A22 (Homo sapiens) 6480464 bisphenol A results in decreased methylation of CYP4A22 gene CTD PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CYP4A1 mRNA and bisphenol A results in decreased expression of CYP4A11 mRNA CTD PMID:25181051 and PMID:32145629 buspirone increases expression EXP 6480464 Buspirone results in increased expression of CYP4A1 mRNA CTD PMID:24136188 carbamazepine decreases expression EXP 6480464 Carbamazepine results in decreased expression of CYP4A1 mRNA CTD PMID:17381134 chlorpyrifos multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CYP4A1 mRNA CTD PMID:33854195 ciprofibrate increases activity EXP 6480464 ciprofibrate results in increased activity of CYP4A1 protein CTD PMID:7676460 ciprofibrate increases expression EXP 6480464 ciprofibrate results in increased expression of CYP4A1 mRNA and ciprofibrate results in increased expression of CYP4A1 protein CTD PMID:19647067 more ... climbazole increases expression EXP 6480464 climbazole results in increased expression of CYP4A1 protein CTD PMID:11552297 clofibrate affects expression EXP 6480464 Clofibrate affects the expression of CYP4A1 mRNA CTD PMID:18246545 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of CYP4A1 mRNA more ... CTD PMID:10476907 more ... clofibrate multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibrate] results in increased expression of CYP4A1 protein and Clofibrate inhibits the reaction [H2AZ1 protein binds to CYP4A1 gene] CTD PMID:10550479 and PMID:28495587 clofibric acid multiple interactions EXP 6480464 Clofibric Acid results in increased expression of and results in increased activity of CYP4A1 protein CTD PMID:15946133 clofibric acid increases expression EXP 6480464 Clofibric Acid results in increased expression of CYP4A1 mRNA CTD PMID:15670589 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of CYP4A1 mRNA CTD PMID:24386269 copper atom multiple interactions EXP 6480464 [Fructose co-treated with Copper deficiency] results in decreased expression of CYP4A1 mRNA and gadolinium chloride promotes the reaction [[Fructose co-treated with Copper deficiency] results in decreased expression of CYP4A1 mRNA] CTD PMID:25813056 copper(0) multiple interactions EXP 6480464 [Fructose co-treated with Copper deficiency] results in decreased expression of CYP4A1 mRNA and gadolinium chloride promotes the reaction [[Fructose co-treated with Copper deficiency] results in decreased expression of CYP4A1 mRNA] CTD PMID:25813056 cortisol increases expression EXP 6480464 Hydrocortisone results in increased expression of CYP4A1 mRNA CTD PMID:10476907 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of CYP4A22 mRNA CTD PMID:19224547 cyhalothrin increases expression EXP 6480464 cyhalothrin results in increased expression of CYP4A1 mRNA CTD PMID:29727961 dehydroepiandrosterone multiple interactions EXP 6480464 Okadaic Acid inhibits the reaction [Dehydroepiandrosterone results in increased expression of CYP4A1 mRNA] CTD PMID:18079279 dehydroepiandrosterone increases expression EXP 6480464 Dehydroepiandrosterone results in increased expression of CYP4A1 mRNA CTD PMID:18079279 and PMID:8700121 dehydroepiandrosterone sulfate increases expression EXP 6480464 Dehydroepiandrosterone Sulfate results in increased expression of CYP4A1 mRNA and Dehydroepiandrosterone Sulfate results in increased expression of CYP4A1 protein CTD PMID:25786523 and PMID:8700121 dehydroepiandrosterone sulfate multiple interactions EXP 6480464 [Dehydroepiandrosterone Sulfate co-treated with Phenobarbital] results in increased expression of CYP4A1 protein CTD PMID:25786523 deoxycholic acid decreases expression EXP 6480464 Deoxycholic Acid results in decreased expression of CYP4A1 protein CTD PMID:10453939 deoxycholic acid multiple interactions EXP 6480464 Ursodeoxycholic Acid inhibits the reaction [Deoxycholic Acid results in decreased expression of CYP4A1 protein] CTD PMID:10453939 Diallyl sulfide decreases expression EXP 6480464 allyl sulfide results in decreased expression of CYP4A1 protein CTD PMID:20116195 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of CYP4A1 mRNA and Dibutyl Phthalate results in increased expression of CYP4A1 protein CTD PMID:15901914 diethyl phthalate increases expression EXP 6480464 diethyl phthalate results in increased expression of CYP4A1 protein CTD PMID:16641546 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of CYP4A22 mRNA CTD PMID:17011747 diquat increases expression EXP 6480464 Diquat results in increased expression of CYP4A1 mRNA CTD PMID:7676460 dodecanoic acid affects metabolic processing EXP 6480464 CYP4A1 protein affects the metabolism of lauric acid CTD PMID:15879494 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of CYP4A1 mRNA and Doxorubicin results in increased expression of CYP4A1 protein CTD PMID:19796650 ethanol multiple interactions EXP 6480464 [Ethanol co-treated with Dietary Fats] results in increased expression of CYP4A1 mRNA more ... CTD PMID:20116195 more ... ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of CYP4A1 mRNA CTD PMID:26854922 ethanol increases expression EXP 6480464 Ethanol results in increased expression of CYP4A1 protein CTD PMID:20116195 farnesol increases activity EXP 6480464 Farnesol results in increased activity of CYP4A1 protein CTD PMID:15840382 felbamate decreases expression EXP 6480464 felbamate results in decreased expression of CYP4A1 mRNA CTD PMID:17381134 fenofibrate affects expression EXP 6480464 Fenofibrate affects the expression of CYP4A1 mRNA CTD PMID:20801182 fenofibrate increases expression ISO CYP4A22 (Homo sapiens) 6480464 Fenofibrate results in increased expression of CYP4A22 mRNA CTD PMID:25572481 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of CYP4A1 mRNA CTD PMID:17264098 more ... fenofibrate multiple interactions EXP 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of CYP4A1 mRNA CTD PMID:18775883 fenvalerate increases activity EXP 6480464 fenvalerate metabolite results in increased activity of CYP4A22 protein CTD PMID:10630566 fenvalerate increases expression EXP 6480464 fenvalerate metabolite results in increased expression of CYP4A22 protein CTD PMID:10630566 fipronil decreases expression EXP 6480464 fipronil results in decreased expression of CYP4A1 mRNA CTD PMID:23962444 fipronil decreases expression ISO CYP4A22 (Homo sapiens) 6480464 fipronil results in decreased expression of CYP4A22 mRNA CTD PMID:27091632 fipronil multiple interactions ISO CYP4A22 (Homo sapiens) 6480464 [fipronil co-treated with DEET] results in decreased expression of CYP4A22 mRNA CTD PMID:27091632 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of CYP4A1 mRNA CTD PMID:24136188 fomepizole multiple interactions EXP 6480464 fomepizole promotes the reaction [Ethanol results in increased expression of CYP4A1 protein] CTD PMID:20116195 fomepizole increases expression EXP 6480464 fomepizole results in increased expression of CYP4A1 protein CTD PMID:20116195 fructose multiple interactions EXP 6480464 [Fructose co-treated with Copper deficiency] results in decreased expression of CYP4A1 mRNA and gadolinium chloride promotes the reaction [[Fructose co-treated with Copper deficiency] results in decreased expression of CYP4A1 mRNA] CTD PMID:25813056 furan decreases expression EXP 6480464 furan results in decreased expression of CYP4A1 mRNA CTD PMID:15120968 and PMID:26194646 gabapentin decreases expression EXP 6480464 gabapentin results in decreased expression of CYP4A1 mRNA CTD PMID:17381134 gadolinium trichloride multiple interactions EXP 6480464 gadolinium chloride promotes the reaction [[Fructose co-treated with Copper deficiency] results in decreased expression of CYP4A1 mRNA] CTD PMID:25813056 gemfibrozil increases expression EXP 6480464 Gemfibrozil results in increased expression of CYP4A1 mRNA CTD PMID:27665778 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of CYP4A1 mRNA CTD PMID:24136188 glyphosate multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CYP4A1 mRNA CTD PMID:33854195 GW 6471 multiple interactions EXP 6480464 perfluorododecanoic acid inhibits the reaction [GW 6471 results in decreased expression of CYP4A1 mRNA] CTD PMID:26168851 GW 6471 decreases expression EXP 6480464 GW 6471 results in decreased expression of CYP4A1 mRNA CTD PMID:26168851 GW 7647 increases expression EXP 6480464 GW 7647 results in increased expression of CYP4A1 mRNA CTD PMID:23315828 Heliotrine decreases expression ISO CYP4A22 (Homo sapiens) 6480464 heliotrine results in decreased expression of CYP4A22 mRNA CTD PMID:26100227 hexadecanoic acid multiple interactions EXP 6480464 [Oleic Acid co-treated with Palmitic Acid co-treated with Ethanol] results in decreased expression of CYP4A1 mRNA CTD PMID:26854922 imidacloprid multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CYP4A1 mRNA CTD PMID:33854195 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CYP4A1 mRNA CTD PMID:22129741 kojic acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP4A22 mRNA and [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYP4A22 mRNA CTD PMID:18544905 lansoprazole increases expression EXP 6480464 Lansoprazole results in increased expression of CYP4A1 protein CTD PMID:9152597 lead nitrate increases expression EXP 6480464 lead nitrate results in increased expression of CYP4A1 mRNA CTD PMID:23391631 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of CYP4A1 mRNA CTD PMID:24136188 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of CYP4A1 mRNA CTD PMID:15120968 methotrexate decreases expression EXP 6480464 Methotrexate results in decreased expression of CYP4A1 mRNA CTD PMID:15120968 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of CYP4A1 mRNA CTD PMID:21515302 N,N-diethyl-m-toluamide decreases expression ISO CYP4A22 (Homo sapiens) 6480464 DEET results in decreased expression of CYP4A22 mRNA CTD PMID:27091632 N,N-diethyl-m-toluamide multiple interactions ISO CYP4A22 (Homo sapiens) 6480464 [fipronil co-treated with DEET] results in decreased expression of CYP4A22 mRNA CTD PMID:27091632 N-acetyl-L-cysteine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CYP4A1 mRNA and Acetylcysteine promotes the reaction [Bezafibrate results in increased expression of CYP4A1 mRNA] CTD PMID:19647067 and PMID:22129741 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibrate] results in increased expression of CYP4A1 protein more ... CTD PMID:10550479 more ... nafenopin multiple interactions EXP 6480464 Okadaic Acid inhibits the reaction [Nafenopin results in increased expression of CYP4A1 mRNA] and tautomycin inhibits the reaction [Nafenopin results in increased expression of CYP4A1 mRNA] CTD PMID:18079279 nafenopin increases expression EXP 6480464 Nafenopin results in increased expression of CYP4A1 mRNA CTD PMID:18079279 and PMID:19647067 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of CYP4A1 mRNA CTD PMID:24136188 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of CYP4A1 mRNA CTD PMID:24136188 O-methyleugenol decreases expression ISO CYP4A22 (Homo sapiens) 6480464 methyleugenol results in decreased expression of CYP4A22 mRNA CTD PMID:32234424 okadaic acid multiple interactions EXP 6480464 Okadaic Acid inhibits the reaction [Dehydroepiandrosterone results in increased expression of CYP4A1 mRNA] and Okadaic Acid inhibits the reaction [Nafenopin results in increased expression of CYP4A1 mRNA] CTD PMID:18079279 oleic acid multiple interactions EXP 6480464 [Oleic Acid co-treated with Palmitic Acid co-treated with Ethanol] results in decreased expression of CYP4A1 mRNA CTD PMID:26854922 orotic acid multiple interactions EXP 6480464 [Sucrose co-treated with Orotic Acid] results in increased expression of CYP4A1 mRNA CTD PMID:15670589 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of CYP4A1 mRNA CTD PMID:23665939 p-tert-Amylphenol increases expression EXP 6480464 4-tert-octylphenol results in increased expression of CYP4A22 mRNA CTD PMID:17011747 paclitaxel increases expression EXP 6480464 Paclitaxel results in increased expression of CYP4A22 mRNA CTD PMID:15585946 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of CYP4A1 mRNA CTD PMID:18246545 and PMID:32479839 pent-4-enoic acid increases expression EXP 6480464 4-pentenoic acid results in increased expression of CYP4A1 mRNA CTD PMID:12883083 perfluorobutyric acid increases expression EXP 6480464 perfluorobutyric acid analog results in increased expression of CYP4A1 mRNA and perfluorobutyric acid results in increased expression of CYP4A1 mRNA CTD PMID:19407336 and PMID:21878386 perfluorododecanoic acid multiple interactions EXP 6480464 perfluorododecanoic acid inhibits the reaction [GW 6471 results in decreased expression of CYP4A1 mRNA] and perfluorododecanoic acid inhibits the reaction [pirinixic acid results in increased expression of CYP4A1 mRNA] CTD PMID:26168851 perfluorododecanoic acid increases expression EXP 6480464 perfluorododecanoic acid results in increased expression of CYP4A1 mRNA CTD PMID:26168851 perfluorohexanoic acid increases expression EXP 6480464 perfluorohexanoic acid results in increased expression of CYP4A1 mRNA CTD PMID:19407336 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid analog results in increased expression of CYP4A1 protein more ... CTD PMID:18923995 more ... perfluorooctane-1-sulfonic acid decreases expression ISO CYP4A22 (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in decreased expression of CYP4A22 mRNA CTD PMID:32790152 perfluorooctane-1-sulfonic acid increases expression ISO CYP4A22 (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in increased expression of CYP4A22 mRNA CTD PMID:27153767 perfluorooctanoic acid increases activity EXP 6480464 perfluorooctanoic acid results in increased activity of CYP4A1 protein CTD PMID:8011682 perfluorooctanoic acid decreases expression ISO CYP4A22 (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of CYP4A22 mRNA CTD PMID:32790152 perfluorooctanoic acid increases expression ISO CYP4A22 (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of CYP4A1 mRNA and perfluorooctanoic acid results in increased expression of CYP4A22 mRNA CTD PMID:21723365 more ... perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of CYP4A1 mRNA and perfluorooctanoic acid results in increased expression of CYP4A1 protein CTD PMID:19162173 more ... phenformin increases expression EXP 6480464 Phenformin results in increased expression of CYP4A1 mRNA CTD PMID:31324951 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of CYP4A1 mRNA CTD PMID:19162173 phenobarbital multiple interactions EXP 6480464 [Dehydroepiandrosterone Sulfate co-treated with Phenobarbital] results in increased expression of CYP4A1 protein CTD PMID:25786523 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of CYP4A1 mRNA CTD PMID:12883083 more ... phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of CYP4A1 protein CTD PMID:9152597 phenylephrine multiple interactions EXP 6480464 20-hydroxy-5 more ... CTD PMID:11124159 and PMID:12388396 phenylephrine increases response to substance EXP 6480464 CYP4A1 protein results in increased susceptibility to Phenylephrine CTD PMID:12388396 phenylephrine affects response to substance EXP 6480464 CYP4A1 protein affects the susceptibility to Phenylephrine CTD PMID:11124159 phenytoin decreases expression EXP 6480464 Phenytoin results in decreased expression of CYP4A1 mRNA CTD PMID:17381134 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid results in increased activity of PPARA protein] which results in increased expression of CYP4A1 mRNA more ... CTD PMID:19103650 and PMID:26168851 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of CYP4A1 mRNA and pirinixic acid results in increased expression of CYP4A1 protein CTD PMID:15635043 more ... pravastatin decreases expression EXP 6480464 Pravastatin results in decreased expression of CYP4A1 mRNA CTD PMID:27225895 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of CYP4A1 mRNA CTD PMID:19162173 and PMID:29548889 propyzamide increases expression EXP 6480464 pronamide results in increased expression of CYP4A1 mRNA CTD PMID:25846364 resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in decreased expression of CYP4A1 mRNA CTD PMID:25905778 rotenone increases expression EXP 6480464 Rotenone results in increased expression of CYP4A1 mRNA CTD PMID:28374803 Senkirkine decreases expression ISO CYP4A22 (Homo sapiens) 6480464 senkirkine results in decreased expression of CYP4A22 mRNA CTD PMID:26100227 simazine increases expression EXP 6480464 Simazine results in increased expression of CYP4A11 protein and Simazine results in increased expression of CYP4A22 protein CTD PMID:9711812 simazine increases activity EXP 6480464 Simazine results in increased activity of CYP4A22 protein CTD PMID:9711812 soybean oil affects expression EXP 6480464 Soybean Oil affects the expression of CYP4A1 mRNA CTD PMID:16079505 streptozocin decreases expression EXP 6480464 Streptozocin results in decreased expression of CYP4A1 mRNA CTD PMID:25905778 streptozocin multiple interactions EXP 6480464 [Dietary Fats co-treated with Streptozocin] results in increased expression of CYP4A1 mRNA more ... CTD PMID:24815820 and PMID:25905778 sucrose multiple interactions EXP 6480464 [Sucrose co-treated with Orotic Acid] results in increased expression of CYP4A1 mRNA CTD PMID:15670589 Sudan III decreases expression EXP 6480464 sudan III results in decreased expression of CYP4A1 mRNA CTD PMID:15585952 sunitinib increases expression EXP 6480464 sunitinib results in increased expression of CYP4A1 mRNA CTD PMID:26797788 tamoxifen decreases expression EXP 6480464 Tamoxifen results in decreased expression of CYP4A22 mRNA CTD PMID:19224547 Tautomycin multiple interactions EXP 6480464 tautomycin inhibits the reaction [Nafenopin results in increased expression of CYP4A1 mRNA] CTD PMID:18079279 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of CYP4A1 mRNA CTD PMID:21515302 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CYP4A1 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of CYP4A1 mRNA CTD PMID:31150632 tetracycline increases expression EXP 6480464 Tetracycline results in increased expression of CYP4A1 mRNA CTD PMID:12883083 tetracycline decreases expression EXP 6480464 Tetracycline results in decreased expression of CYP4A22 mRNA CTD PMID:19224547 thiabendazole multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CYP4A1 mRNA CTD PMID:33854195 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of CYP4A1 mRNA CTD PMID:34492290 toluene increases expression EXP 6480464 Toluene results in increased expression of CYP4A1 protein CTD PMID:8620572 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of CYP4A1 mRNA and Trichloroethylene results in increased expression of CYP4A1 protein CTD PMID:19448997 and PMID:8620572 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of CYP4A1 mRNA CTD PMID:30589522 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of CYP4A1 mRNA CTD PMID:21515302 ursodeoxycholic acid multiple interactions EXP 6480464 Ursodeoxycholic Acid inhibits the reaction [Deoxycholic Acid results in decreased expression of CYP4A1 protein] CTD PMID:10453939 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of CYP4A1 mRNA CTD PMID:17381134 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of CYP4A1 mRNA and Valproic Acid results in increased expression of CYP4A22 mRNA CTD PMID:19224547 and PMID:19850644 zaragozic acid A increases expression EXP 6480464 squalestatin 1 results in increased expression of CYP4A1 mRNA CTD PMID:27225895